vs

Side-by-side financial comparison of Digimarc CORP (DMRC) and SANUWAVE Health, Inc. (SNWV). Click either name above to swap in a different company.

SANUWAVE Health, Inc. is the larger business by last-quarter revenue ($13.4M vs $8.9M, roughly 1.5× Digimarc CORP). SANUWAVE Health, Inc. runs the higher net margin — 57.4% vs -47.2%, a 104.7% gap on every dollar of revenue. On growth, SANUWAVE Health, Inc. posted the faster year-over-year revenue change (30.3% vs 2.9%). SANUWAVE Health, Inc. produced more free cash flow last quarter ($3.2M vs $895.0K). Over the past eight quarters, SANUWAVE Health, Inc.'s revenue compounded faster (53.5% CAGR vs -5.3%).

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

SANUWAVE Health, Inc. is a medical technology company specializing in non-invasive regenerative care solutions. It develops and commercializes shock wave therapy systems for treating chronic wounds, diabetic foot ulcers, and orthopedic conditions, serving healthcare providers and patients across North America, Europe, and key Asia-Pacific markets.

DMRC vs SNWV — Head-to-Head

Bigger by revenue
SNWV
SNWV
1.5× larger
SNWV
$13.4M
$8.9M
DMRC
Growing faster (revenue YoY)
SNWV
SNWV
+27.4% gap
SNWV
30.3%
2.9%
DMRC
Higher net margin
SNWV
SNWV
104.7% more per $
SNWV
57.4%
-47.2%
DMRC
More free cash flow
SNWV
SNWV
$2.3M more FCF
SNWV
$3.2M
$895.0K
DMRC
Faster 2-yr revenue CAGR
SNWV
SNWV
Annualised
SNWV
53.5%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DMRC
DMRC
SNWV
SNWV
Revenue
$8.9M
$13.4M
Net Profit
$-4.2M
$7.7M
Gross Margin
63.5%
74.7%
Operating Margin
-48.2%
15.0%
Net Margin
-47.2%
57.4%
Revenue YoY
2.9%
30.3%
Net Profit YoY
51.4%
157.8%
EPS (diluted)
$-0.18
$0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DMRC
DMRC
SNWV
SNWV
Q4 25
$8.9M
$13.4M
Q3 25
$7.6M
$11.4M
Q2 25
$8.0M
$10.1M
Q1 25
$9.4M
$9.3M
Q4 24
$8.7M
$10.3M
Q3 24
$9.4M
$9.3M
Q2 24
$10.4M
$7.1M
Q1 24
$9.9M
$5.7M
Net Profit
DMRC
DMRC
SNWV
SNWV
Q4 25
$-4.2M
$7.7M
Q3 25
$-8.2M
$9.7M
Q2 25
$-8.2M
$551.0K
Q1 25
$-11.7M
$-6.1M
Q4 24
$-8.6M
$-13.3M
Q3 24
$-10.8M
$-21.2M
Q2 24
$-9.3M
$6.2M
Q1 24
$-10.3M
$-4.8M
Gross Margin
DMRC
DMRC
SNWV
SNWV
Q4 25
63.5%
74.7%
Q3 25
58.3%
76.6%
Q2 25
58.8%
77.3%
Q1 25
65.0%
79.4%
Q4 24
60.8%
78.2%
Q3 24
62.4%
76.1%
Q2 24
66.1%
74.0%
Q1 24
62.5%
73.9%
Operating Margin
DMRC
DMRC
SNWV
SNWV
Q4 25
-48.2%
15.0%
Q3 25
-109.7%
7.9%
Q2 25
-105.2%
14.2%
Q1 25
-128.9%
6.5%
Q4 24
-105.1%
19.6%
Q3 24
-120.4%
16.0%
Q2 24
-96.2%
23.3%
Q1 24
-109.2%
-22.8%
Net Margin
DMRC
DMRC
SNWV
SNWV
Q4 25
-47.2%
57.4%
Q3 25
-106.9%
84.8%
Q2 25
-102.6%
5.4%
Q1 25
-125.2%
-65.8%
Q4 24
-99.9%
-129.5%
Q3 24
-113.9%
-227.8%
Q2 24
-89.3%
87.4%
Q1 24
-104.0%
-84.4%
EPS (diluted)
DMRC
DMRC
SNWV
SNWV
Q4 25
$-0.18
$0.78
Q3 25
$-0.38
$0.39
Q2 25
$-0.38
$-0.04
Q1 25
$-0.55
$-0.72
Q4 24
$-0.40
$-0.76
Q3 24
$-0.50
$-6.65
Q2 24
$-0.43
$0.00
Q1 24
$-0.50
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DMRC
DMRC
SNWV
SNWV
Cash + ST InvestmentsLiquidity on hand
$12.9M
$12.0M
Total DebtLower is stronger
$21.9M
Stockholders' EquityBook value
$40.2M
$1.6M
Total Assets
$53.0M
$37.3M
Debt / EquityLower = less leverage
13.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DMRC
DMRC
SNWV
SNWV
Q4 25
$12.9M
$12.0M
Q3 25
$12.6M
$9.6M
Q2 25
$16.1M
$8.5M
Q1 25
$21.6M
$8.5M
Q4 24
$28.7M
$10.2M
Q3 24
$33.7M
$3.3M
Q2 24
$41.5M
$2.5M
Q1 24
$48.9M
$2.9M
Total Debt
DMRC
DMRC
SNWV
SNWV
Q4 25
$21.9M
Q3 25
$23.3M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DMRC
DMRC
SNWV
SNWV
Q4 25
$40.2M
$1.6M
Q3 25
$41.4M
$-7.6M
Q2 25
$46.5M
$-18.8M
Q1 25
$50.0M
$-20.8M
Q4 24
$61.4M
$-15.8M
Q3 24
$70.2M
$-60.3M
Q2 24
$77.2M
$-39.6M
Q1 24
$84.5M
$-47.6M
Total Assets
DMRC
DMRC
SNWV
SNWV
Q4 25
$53.0M
$37.3M
Q3 25
$55.4M
$35.6M
Q2 25
$60.7M
$33.0M
Q1 25
$66.5M
$30.9M
Q4 24
$75.8M
$30.1M
Q3 24
$85.0M
$21.8M
Q2 24
$93.4M
$21.0M
Q1 24
$99.7M
$23.3M
Debt / Equity
DMRC
DMRC
SNWV
SNWV
Q4 25
13.52×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DMRC
DMRC
SNWV
SNWV
Operating Cash FlowLast quarter
$991.0K
$3.3M
Free Cash FlowOCF − Capex
$895.0K
$3.2M
FCF MarginFCF / Revenue
10.0%
24.1%
Capex IntensityCapex / Revenue
1.1%
0.7%
Cash ConversionOCF / Net Profit
0.43×
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DMRC
DMRC
SNWV
SNWV
Q4 25
$991.0K
$3.3M
Q3 25
$-2.6M
$1.1M
Q2 25
$-4.7M
$993.0K
Q1 25
$-5.5M
$-1.5M
Q4 24
$-4.2M
$741.0K
Q3 24
$-7.1M
$1.3M
Q2 24
$-6.8M
$-668.0K
Q1 24
$-8.4M
$1.1M
Free Cash Flow
DMRC
DMRC
SNWV
SNWV
Q4 25
$895.0K
$3.2M
Q3 25
$-2.8M
$556.0K
Q2 25
$-4.9M
$-166.0K
Q1 25
$-5.5M
$-1.7M
Q4 24
$-4.2M
$505.0K
Q3 24
$-7.2M
$1.2M
Q2 24
$-6.9M
$-760.0K
Q1 24
$-8.5M
$986.0K
FCF Margin
DMRC
DMRC
SNWV
SNWV
Q4 25
10.0%
24.1%
Q3 25
-36.9%
4.9%
Q2 25
-61.0%
-1.6%
Q1 25
-59.1%
-18.1%
Q4 24
-49.1%
4.9%
Q3 24
-75.7%
13.3%
Q2 24
-66.1%
-10.7%
Q1 24
-85.8%
17.3%
Capex Intensity
DMRC
DMRC
SNWV
SNWV
Q4 25
1.1%
0.7%
Q3 25
2.9%
4.6%
Q2 25
2.5%
11.4%
Q1 25
0.6%
1.7%
Q4 24
0.2%
2.3%
Q3 24
0.7%
0.5%
Q2 24
0.3%
1.3%
Q1 24
1.1%
2.0%
Cash Conversion
DMRC
DMRC
SNWV
SNWV
Q4 25
0.43×
Q3 25
0.11×
Q2 25
1.80×
Q1 25
Q4 24
Q3 24
Q2 24
-0.11×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

SNWV
SNWV

Segment breakdown not available.

Related Comparisons